Eton Pharmaceuticals

Historical price data

Eton Pharmaceuticals operates a unique asset-sourcing and accelerated development model to bring therapies for rare diseases to market. Its mission is to make a profoundly positive impact on the lives of small patient populations by identifying late-stage assets and navigating them efficiently through development and approval. Since its 2017 founding, Eton has achieved multiple FDA approvals, validating its capital-efficient strategy and establishing a commercial-stage portfolio.

An integrated business development and operational execution platform focused on sourcing, de-risking, and accelerating the development of late-stage pharmaceutical assets for rare diseases.

Eton competes with specialty pharma companies (e.g., Jazz) and other asset-centric firms. Its advantage lies in agility, deep transactional expertise, and a cost structure optimized for niche rare disease markets, allowing it to pursue opportunities others may bypass.